World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
18153
World Ranking
2689
National Ranking
161

Jean-Paul Viard publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jean-Paul Viard sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 235 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jean-Paul Viard D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Paul Viard sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jean-Paul Viard is affiliated with Assistance Publique - Hôpitaux de Paris in France and specializes in medicine with a focus on infectious diseases and epidemiology. Their research predominantly addresses HIV/AIDS and related viral infections, contributing to multiple facets of HIV research and treatment.

The main fields of study for Viard encompass:

  • Medicine

Their subfields of study highlight the emphasis on:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • Oncology
  • Emergency Medicine

Viard's work covers various topics, particularly within HIV research, including:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments
  • Viral-associated cancers and disorders
  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research

Significant recent papers authored by Viard include:

  • "Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users' ambivalences," 2020, published in AIDS Care
  • "Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users," 2023, published in BMC Infectious Diseases
  • "Introducing an Open-Source Course Management System (Moodle) for Blended learning on infectious diseases and microbiology: A pre-post observational study," 2021, published in Infectious Diseases Now
  • "High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022," 2024, published in Eurosurveillance
  • "Sleep, Prospective Memory, and Immune Status among People Living with HIV," 2021, published in International Journal of Environmental Research and Public Health

Viard frequently publishes in the following venues:

  • The Lancet Regional Health - Europe
  • HIV Medicine
  • AIDS Care
  • BMC Infectious Diseases
  • Eurosurveillance

Frequent co-authors with whom Viard has collaborated include:

  • Jean-Michel Molina
  • Jade Ghosn
  • Laurence Slama
  • Séverine Carillon
  • Lucille Gallardo

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.

    Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus☆

    Jean-Paul Viard;Zahir Amoura;Jean-François Bach

  • Possible role of catheters in Saccharomyces boulardii fungemia.

    C. Hennequin;C. Kauffmann-Lacroix;A. Jobert;J. P. Viard

  • Influence of Age on CD4 Cell Recovery in Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy: Evidence from the EuroSIDA Study

    Jean-Paul Viard;Amanda Mocroft;Antonio Chiesi;Ole Kirk

  • Chronic renal failure among HIV-1-infected patients

    Amanda Mocroft;Ole Kirk;Jose Gatell;Peter Reiss

  • Overproduction of Proinflammatory Cytokines Imbalanced by Their Antagonists in POEMS Syndrome

    RK Gherardi;L Belec;M Soubrier;D Malapert

  • Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts

    Laurent Hocqueloux;Véronique Avettand-Fènoël;Véronique Avettand-Fènoël;Sophie Jacquot;Thierry Prazuck

  • Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection.

    Laurent Hocqueloux;Thierry Prazuck;Véronique Avettand-Fenoel;Alain Lafeuillade

  • Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level.

    Jean-Paul Viard;Marianne Burgard;Jean-Baptiste Hubert;Laurent Aaron

  • Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.

    Jean-Paul Viard;Jean-Claude Souberbielle;Ole Kirk;Joanne Reekie

  • Early Levels of HIV-1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV-1 RNA Levels and CD4+ T Cell Counts

    Christine Rouzioux;Jean-Baptiste Hubert;Marianne Burgard;Christiane Deveau

  • Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.

    François Rouet;Marie-Laure Chaix;Eric Nerrienet;Nicole Ngo-Giang-Huong

  • Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.

    Philippe Lesprit;Bertrand Godeau;Francois-Jérôme Authier;Martin Soubrier

  • Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection : a randomised controlled trial

    Y Levy;C Capitant;S Houhou;I Carriere

  • Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

    Véronique Avettand-Fènoël;Véronique Avettand-Fènoël;Laurent Hocqueloux;Jade Ghosn;Antoine Cheret

  • Rituximab therapy for HIV-associated Castleman disease.

    Anne-Geneviève Marcelin;Laurent Aaron;Christine Mateus;Emmanuel Gyan

  • Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.

    A. Hot;C. Maunoury;S. Poiree;F. Lanternier

Frequent Co-Authors

Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital
Marc Lecuit
Marc Lecuit Institut Pasteur
Véronique Avettand-Fenoel
Véronique Avettand-Fenoel Necker-Enfants Malades Hospital
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Marie-Laure Chaix
Marie-Laure Chaix Université Paris Cité
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Jade Ghosn
Jade Ghosn Hôpital Bichat - Claude-Bernard (Hôpitaux Universitaires Paris Nord Val de Seine)
Bertrand Dupont
Bertrand Dupont Necker-Enfants Malades Hospital
Olivier Lortholary
Olivier Lortholary Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career opportunities beyond traditional lab roles. Many graduates explore fields like medical coding and health information management, which combine healthcare knowledge with technology and data analysis.

For those interested in coding, becoming a certified professional coder is a popular pathway, offering competitive earnings and job stability. To learn more about earning potential in this area, explore the cpc medical coding salary insights. Rapidly entering the workforce is also possible through the quickest medical billing and coding certificate online programs, allowing students to upskill efficiently.

For those interested in managing healthcare data, pursuing a bachelor's degree in health information management offers strong career prospects. Salaries and opportunities can be found in detail at health information management bachelor degree salary. To ensure quality education, students should consider cahiim accredited health information management programs online that align with industry standards and accreditation requirements.

Overall, combining a microbiology background with skills in medical coding or health information management offers a dynamic and rewarding career trajectory in the expanding healthcare sector.

Best Scientists Citing Jean-Paul Viard

Trending Scientists

Recently Published Articles